Netflix's ongoing content success, now including games and live content, leads 24/7 Wall St. to project huge upside for the ...

Due to Tesla's innovation and diversification, 24/7 Wall St. sees strong upside potential for the stock by the end of the decade.

Markets are assessing the reshaped US trade landscape after Trump on Thursday laid out steep new tariffs for dozens of ...

Rivian stock has trended upward recently despite facing challenges. Here is a look at where the stock could be in a year.

Justin Pope has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ASML, Alphabet, ...

Celcuity (NASDAQ:CELC) has announced the pricing of two underwritten public offerings. The first is a $175 million offering ...

The upper end of that revenue run rate would give Nebius a price-to-sales (P/S) ratio of about 12.5, even after the stock's recent surge. That appears to be a reasonable valuation for such a fast ...

Palantir (NASDAQ: PLTR) stock saw a massive rally across the first half of 2025's trading. The tech company's share price rose 80.3% across the stretch against the backdrop of a 5.5% gain for the S&P ...

InflaRx has been granted an initial 180-day period to regain compliance with Nasdaq's minimum bid price requirement, allowing the company time to address the issue without immediate pressure.

AGM Group Holdings Inc. announced that on June 18, 2025, it received a Compliance Letter from Nasdaq confirming its adherence to the bid price requirement under Nasdaq Listing Rule 5550 (a) (2).

NEW YORK, July 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. ("Klotho" or the "Company") (NASDAQ: KLTO), a gene and cell therapy company focused on the treatment of neurodegenerative and ...

In accordance with Nasdaq Listing Rule 5810 (c) (3) (A), the Company has been provided an initial period of 180 calendar days, or until January 7, 2026, to regain compliance.